Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses

US5703088A · kind A · utility

Assignee

• Beth Israel Deaconess Medical Center, Inc. · US

Inventors

• Richard J. Sharpe · Gloucester, US
• Kenneth A. Arndt · Newton, US
• Stephen J. Galli · Portola Valley, US
• Peter Meltzer · Lexington, US
• Raj K. Razdan · Belmont, US
• Howard Sard · Arlington, US

Key dates

• Filing date: Jun 4, 1992
• Grant date: Dec 30, 1997
• Expiry date: Jun 4, 2012

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61Q7/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A method for the treatment of a cutaneous, ocular, or mucosal pathological condition which is associated with immune response in a human or other mammal, that includes topical application of an effective amount of spiperone or a spiperone derivative or its pharmaceutically acceptable salt, in a pharmaceutically-acceptable diluent or carrier for topical application.